- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-9158
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
How to optimize the treatment of early stage Parkinson’s disease ; volume:4 ; number:1 ; day:25 ; month:2 ; year:2015 ; pages:1-7 ; date:12.2015
Translational neurodegeneration ; 4, Heft 1 (25.2.2015), 1-7, 12.2015
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Stocchi, Fabrizio
- Beteiligte Personen und Organisationen
-
Vacca, Laura
Radicati, Fabiana G.
SpringerLink (Online service)
- DOI
-
10.1186/2047-9158-4-4
- URN
-
urn:nbn:de:1111-201709124172
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stocchi, Fabrizio
- Vacca, Laura
- Radicati, Fabiana G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Disrupted morphological grey matter networks in early-stage Parkinson’s disease
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Muscle activation strategies of people with early-stage Parkinson’s during walking
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Semi-automated approaches to optimize deep brain stimulation parameters in Parkinson’s disease
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
Pinpointing the precise stimulation targets for brain rehabilitation in early-stage Parkinson’s disease
Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
Disrupted morphological grey matter networks in early-stage Parkinson’s disease
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Muscle activation strategies of people with early-stage Parkinson’s during walking
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Semi-automated approaches to optimize deep brain stimulation parameters in Parkinson’s disease
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
Pinpointing the precise stimulation targets for brain rehabilitation in early-stage Parkinson’s disease
Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
Disrupted morphological grey matter networks in early-stage Parkinson’s disease
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Muscle activation strategies of people with early-stage Parkinson’s during walking
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Semi-automated approaches to optimize deep brain stimulation parameters in Parkinson’s disease
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
Pinpointing the precise stimulation targets for brain rehabilitation in early-stage Parkinson’s disease
Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease